Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
Vincenza Ylenia Cusenza, Annalisa Tameni, Antonino Neri, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 8
Super-enhancer-driven SLCO4A1-AS1 is a new biomarker and a promising therapeutic target in glioblastoma
Yibo Wu, Fang Li, Chen Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A novel prognostic signature based on m5C‑related LncRNAs and its immunological characteristics in colon adenocarcinoma
Zhenzhen Liu, Sheng Chang, Shuo Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
Chubei Teng, Yongwei Zhu, Yueshuo Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Deciphering glioma epitranscriptome: focus on RNA modifications
Christina Piperi, Mariam Markouli, Antonios N. Gargalionis, et al.
Oncogene (2023) Vol. 42, Iss. 28, pp. 2197-2206
Closed Access | Times Cited: 12
5-methylcytosine-mediated upregulation of circular RNA 0102913 augments malignant properties of colorectal cancer cells through a microRNA-571/Rac family small GTPase 2 axis
Chaofeng Hou, Jinbo Liu, Junwei Liu, et al.
Gene (2024) Vol. 901, pp. 148162-148162
Closed Access | Times Cited: 4
RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming
Dali Yan, Yongsong Xie, Liyuan Huang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 16, pp. 2398-2411
Open Access | Times Cited: 9
Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma
Ami Kobayashi, Yosuke Kitagawa, Ali M. Nasser, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 457-457
Open Access | Times Cited: 3
Deciphering the vital roles and mechanism of m5C modification on RNA in cancers.
Lemei Zheng, Yumei Duan, Mengna Li, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 6125-6146
Closed Access | Times Cited: 7
Linc00265 in human disease: A comprehensive analysis of its implications in human disease pathobiology and therapeutic prospect
Wankang Dian, Wenkai Zhang, Luyu Yang, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155409-155409
Closed Access | Times Cited: 2
The role of m5C RNA modification in cancer development and therapy
Li Yu, Hongen Xu, Hanchu Xiong, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38660-e38660
Open Access | Times Cited: 2
Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics
Ágota Tűzesi, Susannah Hallal, Laveniya Satgunaseelan, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1232-1232
Open Access | Times Cited: 5
A Transcription Factor ZNF384, Regulated by LINC00265, Activates the Expression of IFI30 to Stimulate Malignant Progression in Glioma
Jian Yang, Shenghe Yang, Jinlian Cai, et al.
ACS Chemical Neuroscience (2023) Vol. 15, Iss. 2, pp. 290-299
Closed Access | Times Cited: 4
Zinc Finger and BTB Domain-Containing 20: A Newly Emerging Player in Pathogenesis and Development of Human Cancers
Jiangyuan Liu, Han Zhang
Biomolecules (2024) Vol. 14, Iss. 2, pp. 192-192
Open Access | Times Cited: 1
Latest updates on cellular and molecular biomarkers of gliomas
Maroun Bou Zerdan, Ali Atoui, Ali Hijazi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
The role of RNA modification in the generation of acquired drug resistance in glioma
Yu Yan, Wei Wei, Shengrong Long, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Integrative analysis of multi-omics data reveals a pseudouridine-related lncRNA signature for prediction of glioma prognosis and chemoradiotherapy sensitivity
Yanbo Yang, Fei Wang, Haiying Teng, et al.
Computers in Biology and Medicine (2023) Vol. 166, pp. 107428-107428
Open Access | Times Cited: 3
Immune depletion of the methylated phenotype of colon cancer is closely related to resistance to immune checkpoint inhibitors
Cheng‐Qian Zhong, Tingjiang Xie, Long Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Unveiling the role of RNA methylation in glioma: Mechanisms, prognostic biomarkers, and therapeutic targets
Qichen Xu, Chunsong Yang, Liyun Wang, et al.
Cellular Signalling (2024) Vol. 124, pp. 111380-111380
Closed Access
Prognosis and Novel Drug Targets for Key lncRNAs of Epigenetic Modification in Colorectal Cancer
Peng Zhang, Tingting Zhang, Denggang Chen, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 1
Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data
Hongying Zhao, Siwen Zhang, Xiangzhe Yin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 2
Identification of a Novel Disulfideptosis-Related LncRNA Signature and Integrative Analyses in Patients with Gliomas
Kai-hua Cao, Sai Li, Qi Liu, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top